Aurinia Pharmaceuticals
AUPH
AUPH
215 hedge funds and large institutions have $493M invested in Aurinia Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 68 increasing their positions, 62 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less capital invested
Capital invested by funds: $499M → $493M (-$5.13M)
2.04% less ownership
Funds ownership: 45.14% → 43.1% (-2%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
215
Holding in Top 10
1
Calls
$12.9M
Puts
$7.42M
Top Buyers
| 1 | +$5.57M | |
| 2 | +$3.65M | |
| 3 | +$3.27M | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
+$2.87M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$2.75M |
Top Sellers
| 1 | -$28.5M | |
| 2 | -$10.1M | |
| 3 | -$9.03M | |
| 4 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
-$8.3M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.78M |
